Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cynata Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
Biotech: It’s not a get-rich-quick scheme judging by these HY reports
Health & Biotech
Sepsis has tripled in Australia and these small caps are tackling it head on
Health & Biotech
Cancer Wars Part 1: These are the ASX small cap drugmakers that want to conquer cancer
Health & Biotech
Check up: Enthusiasm rather than news is moving health stocks
Health & Biotech
Biotech: Cynata wins first round against sepsis bugs
Health & Biotech
Health & Biotech: Mesoblast still not in the black, but they’re less in the red than last year
Health & Biotech
Health: Botanix buddy set to benefit after DEA admits their synthetic CBD is probably ok
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
Health & Biotech
Health: Resonance Health says cash receipts continue to grow, but investors are looking for more
Health & Biotech
Health: the hits keep coming for Avecho Biotechnology
Health & Biotech
The life sciences investment wave is building. Here’s how to ride it.
Health & Biotech
When is the right time for a biotech to try and woo big pharma?
News
Lunchtime ASX small cap wrap: Who’s pointing the finger today?
Health & Biotech
Health: Cynata has finally scored that Fujifilm deal; shares climb 27pc
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: Orthocell has done it again as patients regain shoulder function following CelGro surgery
Health & Biotech